Location: IRS2, 22 Bd. Bénoni Goullin 44200 Nantes - Room 1
Kathleen Ducoin (team 3) will present her thesis entitled: Etude des réponses lymphocytaires CD8 antitumorales et modulation par les " Immune Checkpoints " dans le cancer colorectal humain on December 2 at 14.00 at IRS2, Nantes
INCIT in the spotlight at the "Go Immuno" conference organized by Labex IGO in December. In...
HORIZON Europe Framework Program : coordinated by F. ALTARE INCIT joins the RAISE network...
Seminar Speaker: Charlotte Michaux (U1230 - Rennes) Location: April 23, 11.00 - Rooms 1, 2, 3 -...
ReNAissance is one of the projects selected by the Impact Santé program, an initiative...
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
The INCIT unit is pleased to announce that it has been awarded an ambitious European program on immunotherapy, bringing together 7 partners (including 2 biotechs) in 4 European countries. This program is coordinated by Frédéric ALTARE, Director of the UMR 1302, INCIT in Nantes. Project title: immunotherapy of inflammatory bowel diseases
The Angevine team has invited Charlotte Michaux from U1230 to Rennes on April 23 at 11.00. Title of her seminar: When Antibiotics Fail: Understanding Bacterial Persistence During Infection.
ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...